| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Andrey Semechkin
Also a director
Chief Executive Officer
|
66 | Not stated | Not stated | $88,544 | |
|
Russell Kern
Also a director
Executive Vice President, Chief Scientific Officer and Principal Financial Officer
|
40 | Not stated | Not stated | $370,000 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Unsecured, non-convertible promissory note issued by the Company to Dr. Semechkin, bearing 4.5% interest and due September 15, 2024.
Replacement promissory note issued to Dr. Semechkin after $200,000 principal repayment, at 5.5% interest with maturity extended to September 15, 2025.
Joint lease with Rehco Holdings, LLC for the corporate headquarters, with costs allocated between the Company and S Real Estate Holdings LLC under a co-tenant agreement; Dr. Kern personally guaranteed the lease.
Loading...
